<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04637386</url>
  </required_header>
  <id_info>
    <org_study_id>AFP and Miscarriage</org_study_id>
    <nct_id>NCT04637386</nct_id>
  </id_info>
  <brief_title>Alpha-fetoprotein in Early Pregnancy Failure</brief_title>
  <official_title>the Role of Alpha-fetoprotein in the Prediction of Early Pregnancy Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Early pregnancy loss is a common obstetric complication and is often preceded by vaginal&#xD;
      bleeding. Î±-fetoprotein (AFP) is produced by the yolk sac and later in the fetal liver and&#xD;
      can be measured as early as the fifth week of gestation. Our study is to determine if&#xD;
      alpha-fetoprotein (AFP) concentration in vaginal blood, in the setting of dissolved fetal&#xD;
      tissue, is significantly higher than its concentration in the maternal serum.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 15, 2020</start_date>
  <completion_date type="Anticipated">May 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vaginal blood AFP/ maternal serum AFP ratio</measure>
    <time_frame>6 hours</time_frame>
    <description>Comparing AFP concentration in the vaginal blood with the AFP concentration in the maternal blood</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Alpha-Fetoprotein</condition>
  <condition>Early Pregnancy Loss</condition>
  <arm_group>
    <arm_group_label>Group A (inevitable/incomplete abortion):</arm_group_label>
    <description>Includes 15 patients with severe vaginal bleeding or part of the product of conception pass through the cervix, cx opened, and -ve fetal pulse.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B (with vaginal bleeding during cerclage placement):</arm_group_label>
    <description>Includes 15 patients with vaginal bleeding during cerclage</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        A total of 30 pregnant women aged 18-40 years in the first or the second trimester with&#xD;
        symptoms of possible pregnancy failure (vaginal bleeding).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Women in the reproductive-age group between 18 to 39 years old.&#xD;
&#xD;
          2. Women with single intra-uterine pregnancy.&#xD;
&#xD;
          3. Women with gestation age correctly dated by trans vaginal at the time of the first or&#xD;
             second trimester.&#xD;
&#xD;
          4. Women who are medically free.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Women with twin or multiple pregnancies.&#xD;
&#xD;
          2. Threatened abortion with +ve fetal pulsation.&#xD;
&#xD;
          3. anembryonic pregnancy, complete vesicular mole.&#xD;
&#xD;
          4. Women with a gestation age of more than 25 weeks.&#xD;
&#xD;
          5. Women with s medical diseases such as diabetes, liver cancer, ovarian cancer,&#xD;
             hepatitis, renal cell carcinoma.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammed A Taymour, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>waleed M El-khayat, MD</last_name>
    <phone>01005135542</phone>
    <email>waleed_elkhyat@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>faculty of medicine - Cairo university</name>
      <address>
        <city>Cairo</city>
        <state>Kasr El Ainy</state>
        <zip>11562</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>mohamed T aneis, MD</last_name>
      <phone>202 23653269</phone>
    </contact>
    <investigator>
      <last_name>waleed M El khyat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 15, 2020</study_first_submitted>
  <study_first_submitted_qc>November 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 19, 2020</study_first_posted>
  <last_update_submitted>November 15, 2020</last_update_submitted>
  <last_update_submitted_qc>November 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>ahmed nagy shaker ramadan</investigator_full_name>
    <investigator_title>assistant lecture of obstetrics and gynecology</investigator_title>
  </responsible_party>
  <keyword>Alpha-Fetoprotein</keyword>
  <keyword>Early Pregnancy Loss</keyword>
  <keyword>Miscarriage</keyword>
  <keyword>pregnancy failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abortion, Spontaneous</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

